Ionis Pharmaceuticals (IONS) Ownership - Who owns Ionis Pharmaceuticals?

Industry: @Biotechnology
18 days until earnings call

Profile

Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
927
Web
https://www.ionispharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.98B
P/E Ratio
N/A
Total Cash
2.21B
Projected Growth
N/A
Total Debt
1.44B
Revenue
776.62M
Risk (Beta)
0.16
Dividend Yield
N/A
Total Cash/Share
15.11
Total Debt/Equity
N/A
Revenue/Share
5.40 USD as % of share price

Fundamentals

IONS
Capitalization
6.98B
P/E Ratio
N/A
Risk (Beta)
0.16
Dividend Yield
N/A
Total Cash
2.21B
Total Cash/Share
15.11
Total Debt
1.44B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.40%
Revenue
777M
ROE
N/A
Book Value
297M
P/B Ratio
23.53
Cash Flow
N/A
Earnings
-2.67
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
146K
Current Ratio
7.37
Current Revenue Per Employee
128907.23
Dividends Per Share - Security
N/A
EBITDA
-260.87M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.20
Revenue To Assets
-13.62
Shares Held By Institutions
16.4B
Shares Outstanding - Current
146M
Total Liabilities
2.47B
Total Volume MTD
N/A
Value
-1
Gain YTD
-5.475
View a ticker or compare two or three
IONS
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of antisense drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
927
Web
https://www.ionispharma.com